These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 26230119)

  • 1. In vitro susceptibility of a penicillin-resistant and tolerable isolate of Streptococcus pneumoniae to combination therapy.
    Majhi A; Nandi A; Adhikary R; Mahanti S; Bishayi B
    J Infect Dev Ctries; 2015 Jul; 9(7):702-9. PubMed ID: 26230119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bactericidal activity of cefepime and ceftriaxone tested against Streptococcus pneumoniae.
    Pottumarthy S; Sader HS; Jones RN
    Diagn Microbiol Infect Dis; 2007 Mar; 57(3):345-9. PubMed ID: 17141459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro synergy of penicillin, ceftriaxone and levofloxacin against serotype 19A Streptococcus pneumoniae.
    Tsai HY; Liao CH; Liu CY; Huang YT; Hsueh PR
    Int J Antimicrob Agents; 2015 Dec; 46(6):722-5. PubMed ID: 26453149
    [No Abstract]   [Full Text] [Related]  

  • 4. Ceftriaxone acts synergistically with levofloxacin in experimental meningitis and reduces levofloxacin-induced resistance in penicillin-resistant pneumococci.
    Flatz L; Cottagnoud M; Kühn F; Entenza J; Stucki A; Cottagnoud P
    J Antimicrob Chemother; 2004 Feb; 53(2):305-10. PubMed ID: 14729741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamic analysis of ceftriaxone, gatifloxacin,and levofloxacin against Streptococcus pneumoniae with the use of Monte Carlo simulation.
    Frei CR; Burgess DS
    Pharmacotherapy; 2005 Sep; 25(9):1161-7. PubMed ID: 16164390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of cefditoren and other antimicrobial agents against 288 Streptococcus pneumoniae and 220 Haemophilus influenzae clinical strains isolated in Zaragoza, Spain.
    Seral C; Suárez L; Rubio-Calvo C; Gómez-Lus R; Gimeno M; Coronel P; Durán E; Becerril R; Oca M; Castillo FJ
    Diagn Microbiol Infect Dis; 2008 Oct; 62(2):210-5. PubMed ID: 18715733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the activity of ceftaroline against clinical isolates of penicillin-intermediate and penicillin-resistant Streptococcus pneumoniae with elevated MICs of ceftaroline using an in vitro pharmacodynamic model.
    Zhanel GG; Yachison C; Nichol K; Adam H; Noreddin AM; Hoban DJ; Karlowsky JA
    J Antimicrob Chemother; 2012 Jul; 67(7):1706-11. PubMed ID: 22467630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences between ceftriaxone and cefotaxime: microbiological inconsistencies.
    Gums JG; Boatwright DW; Camblin M; Halstead DC; Jones ME; Sanderson R
    Ann Pharmacother; 2008 Jan; 42(1):71-9. PubMed ID: 18094350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time-kill evaluation of antimicrobial regimens against clinical isolates of penicillin-resistant Streptococcus pneumoniae.
    Bañón Arias R; García López M; Pinedo Sánchez A
    J Chemother; 2001 Oct; 13(5):535-40. PubMed ID: 11760218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effectiveness of the antibiotics chloramphenicol and rifampin in the treatment of Streptococcus pneumoniae-induced meningitis and systemic infections].
    Hernández M; Mejía GI; Trujillo H; Robledo J
    Biomedica; 2003 Dec; 23(4):456-61. PubMed ID: 14968923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Carrier rate of Streptococcus pneumoniae and susceptibility thereof to antimicrobial drugs among children in China: a surveillance study in Beijing, Shanghai, and Guangzhou 2000-2002].
    Yao KH; Lu Q; Deng L; Yu SJ; Zhang H; Deng QL; Shen XZ; Yang YH
    Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(28):1957-61. PubMed ID: 16313770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro susceptibility of Streptococcus pneumoniae strains to nine beta-lactam antibiotics and the killing kinetics of cephalosporins alone and in combination with vancomycin or gentamicin.
    Marton A; Major P
    Microb Drug Resist; 1996; 2(3):361-9. PubMed ID: 9158796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of pneumolysin and autolysin genes among antibiotic resistant Streptococcus pneumoniae in invasive infections.
    Sourav S; Patricia A; Sharma S; Kanungo R; Jayachandran S; Prashanth K
    Indian J Med Microbiol; 2010; 28(1):34-9. PubMed ID: 20061761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changing antimicrobial susceptibility patterns among Streptococcus pneumoniae and Haemophilus influenzae from Brazil: Report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Castanheira M; Gales AC; Pignatari AC; Jones RN; Sader HS
    Microb Drug Resist; 2006; 12(2):91-8. PubMed ID: 16922623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Jones RN; Sader HS; Fritsche TR; Pottumarthy S
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro infection model characterizing the effect of efflux pump inhibition on prevention of resistance to levofloxacin and ciprofloxacin in Streptococcus pneumoniae.
    Louie A; Brown DL; Liu W; Kulawy RW; Deziel MR; Drusano GL
    Antimicrob Agents Chemother; 2007 Nov; 51(11):3988-4000. PubMed ID: 17846144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fractional maximal effect method for in vitro synergy between amoxicillin and ceftriaxone and between vancomycin and ceftriaxone against Enterococcus faecalis and penicillin-resistant Streptococcus pneumoniae.
    Desbiolles N; Piroth L; Lequeu C; Neuwirth C; Portier H; Chavanet P
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3328-33. PubMed ID: 11709304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic options for pneumococcal pneumonia in Turkey.
    Oncu S; Erdem H; Pahsa A
    Clin Ther; 2005 Jun; 27(6):674-83. PubMed ID: 16117975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial susceptibility of multidrug-resistant Streptococcus pneumoniae strains with penicillin MICs of 8 to 32 mg/L.
    Rodríguez-Cerrato V; Gracia M; Del Prado G; Huelves L; Naves P; Ruiz V; Ponte C; Soriano F
    Diagn Microbiol Infect Dis; 2010 Mar; 66(3):336-8. PubMed ID: 19939599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility and bactericidal activity of 8 oral quinolones against conventional-fluoroquinolone-resistant Streptococcus pneumoniae clinical isolates.
    Yokota S; Ohkoshi Y; Fujii N
    Diagn Microbiol Infect Dis; 2009 Sep; 65(1):76-80. PubMed ID: 19679241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.